Stage III Lung Cancer: Improving cure rates with radiation and drugs
In early-stage (stage I) non-small cell lung cancer (NSCLC), high-dose radiation can be used in lieu of surgery to cure patients. Whether radiation therapy or surgery is performed
In early-stage (stage I) non-small cell lung cancer (NSCLC), high-dose radiation can be used in lieu of surgery to cure patients. Whether radiation therapy or surgery is performed
Early-stage lung cancer patients are frequently treated, and often cured, with surgery. Over the past 15 years, new technologies have made surgical outcomes for early-stage lung
The success we have seen with targeted therapeutics for EGFR-mutated or ALK-rearranged lung cancers has not been demonstrated in KRAS-positive tumors. I am really excited that that
After losing both parents to lung cancer, Dr. Timothy Burns, now an oncologist and researcher specializing in lung cancer at the University of Pittsburgh, committed himself to
Lecia Sequist, MD, MPH, the Landry Family Associate Professor of Medicine at Harvard Medical School and a thoracic oncologist at the Massachusetts General Hospital Cancer Center as
Based on what I learned at the 17th Annual Targeted Therapies of the Treatment of Lung Cancer conference in February in Santa Monica, California, 2017 is going to be an important
Patrick Forde, MD, has a lot of experience running clinical trials. At any given time, he is running five to ten active clinical trials for patients with lung cancer at Johns
Each year Viswam Nair, MD, manages treatment plans for hundreds of patients at Stanford University . A pulmonologist with formal training in epidemiology, Dr. Nair stays current on
Targeted therapies continue to be an important treatment option for those patients whose tumors test positive for an actionable mutation for which a drug exists. I chatted with Dr